Corient Private Wealth LLC Grows Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Corient Private Wealth LLC increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.0% in the 4th quarter, HoldingsChannel reports. The fund owned 86,700 shares of the financial services provider’s stock after acquiring an additional 841 shares during the period. Corient Private Wealth LLC’s holdings in iShares Biotechnology ETF were worth $11,778,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Glass Jacobson Investment Advisors llc grew its position in iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 122 shares in the last quarter. Northwest Financial Advisors bought a new stake in iShares Biotechnology ETF in the fourth quarter worth about $42,000. Values First Advisors Inc. bought a new stake in iShares Biotechnology ETF in the fourth quarter worth about $43,000. Tennessee Valley Asset Management Partners bought a new stake in iShares Biotechnology ETF in the fourth quarter worth about $44,000. Finally, Massmutual Trust Co. FSB ADV lifted its stake in iShares Biotechnology ETF by 164.2% in the fourth quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 225 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock traded up $0.04 on Friday, hitting $135.67. 1,594,141 shares of the company traded hands, compared to its average volume of 1,393,269. The stock’s 50 day moving average price is $132.75 and its 200-day moving average price is $131.94. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were paid a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.37%. The ex-dividend date of this dividend was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.